Farnesoid X receptor (FXR), the receptor for bile acids, including chenodeoxycholic acid (CDCA), is a member of the nuclear receptor superfamily, which also includes the receptors for retinoic acid, vitamin D (D3), thyroid hormone, thiazolidinedione and 22(R)-hydroxycholesterol. Here, we have evaluated the effects of a series of ligands and their receptors on the promoter activity induced by CDCA/FXR. The kidney cell line, CV1, was cotransfected with FXR-expression plasmid and the luciferase-based reporter gene that has a thymidine kinase promoter fused to the canonical FXR-responsive element or the natural promoter for the small heterodimer partner (SHP), bile salt export pump (BSEP), and ileum bile acid (I-BABP) gene. D3 and its receptor (VDR) inhibited the transactivation of all four reporter constructs that are enhanced by CDCA/FXR. The effect of D3 on the expression of the BSEP and SHP genes in HepG2 cells and that of the I-BABP gene in Caco-2 cells were confirmed by reverse transcription (RT)-PCR. Deletion analysis of VDR revealed that its ligand-binding domain (LBD) is responsible for the repression and the DNA-binding domain (DBD) is dispensable. Specific interaction between FXR and VDR was detected with the in vitro pull-down assay using chimeric FXR or VDR fused to glutathione-S-transferase.
Introduction
Farnesoid X receptor (FXR) functions as the receptor for bile acids such as chenodeoxycholic acid (CDCA) (Chawla et al. 2001) . In the liver, bile acid is synthesized from cholesterol with cholesterol 7 -hydroxylase (CYP7A1) as the rate-limiting enzyme (Chawla et al. 2001) . The expression of CYP7A1 is negatively regulated by the transcription factor small heterodimer partner (SHP), the expression of which is enhanced by the ligand-bound FXR. Consequently, bile acid suppresses the expression of CYP7A1 in vivo via FXR, resulting in a decrease in its own production. On the other hand, the metabolism of bile acid is precisely regulated in the enterohepatic circulation, where the bile salt export pump (BSEP) and the ileum bile acid transporter (I-BABP) play critical roles. BSEP mediates the ATP-dependent transport of bile salts across the canalicular membrane of hepatocytes (Ananthanarayanan et al. 2001 , Plass et al. 2002 , whereas I-BABP, which is a cytosolic protein expressed in the ileum, binds bile acid with a high affinity to mediate its cytosolic transportation (Grober et al. 1999 ). Short DNA sequences, referred to as FXR-responsive elements (FXREs) , are present in the promoters of the SHP (Goodwin et al. 2000 , Lu et al. 2000 , BSEP (Ananthanarayanan et al. 2001) and I-BABP genes (Grober et al. 1999) . On the FXREs, FXR forms a heterodimer with retinoid X receptor (RXR) and stimulates transcription in a bile acid-dependent manner. 22(R)-hydroxycholesterol (22(R)-HC) (Janowski et al. 1996) is the ligand for liver X receptor (LXR ) (Willy et al. 1995) . 22(R)-HC and LXR directly stimulate the LXR-responsive element in CYP7A1 gene, while liganded FXR downregulates the transcription of CYP7A1 by the induction of SHP (Lu et al. 2000) .
Small lipophilic hormones and ligands, such as retinoic acid (RA), 1,25-dihydroxyvitamin D 3 (D3), thyroid hormones (tri-iodothyronine (T 3 ) and thyroxine (T 4 )), thiazolidinedione (TZD), and oxysterol, bind and activate RA receptor (RAR), D3 receptor (VDR), T 3 receptor (TR), peroxisome proliferator-activated receptor 2 (PPAR 2) and LXR respectively (McKenna et al. 2002) . It should be noted that the synthesis and enterohepatic circulation of bile acid have profound effects on the absorption and metabolism of these lipophilic ligands from the intestine. For example, severe malabsorption of D3 and vitamin A (a precursor of RA) has been reported in patients with progressive familial intrahepatic cholestasis type 2 (PFIC2) (Whitington et al. 1994) , in which a genetic abnormality of the BSEP causes the impairment of bile acid excretion from hepatocytes (Thompson & Strautnieks 2001) . The enterohepatic circulation of bile acid also affects the intestinal uptake of T 4 (DiStefano et al. 1993) and TZD (Kawai et al. 2000) . In this study, we evaluated the effects of the liganded receptors on the CDCA/FXR-dependent transactivation of the reporter genes, including canonical FXRE fused to the thymidine kinase (tk) promoter and the natural promoters for BSEP, I-BABP or SHP. We observed that VDR suppresses the transactivation driven by CDCA/FXR in a D3-dependent manner. Glutathione-S-transferase (GST) pull-down assay revealed the specific interaction between FXR and VDR.
Materials and Methods

Plasmids
With human genomic DNA as the template, the BSEP promoter regions of the BSEP gene (-165 to +8) (Ananthanarayanan et al. 2001 ) and the SHP gene (-332 to +10) (Lee et al. 1998) were amplified by PCR. Both PCR products were digested with NheI and HindIII, and subcloned into pGL2-Basic Vector (Promega) to generate hBSEP-Luc and hSHP-Luc. The parental plasmid (pCMX) for rat FXR (pCMX-rFXR), human RAR (pCMX-hRAR ), human TR 1 (pCMX-hTR 1) (Umesono et al. 1991) and human LXR (pCMXhLXR ) (Willy et al. 1995) is driven by the cytomegalovirus (CMV) promoter (Umesono et al. 1991) . The parental plasmid (pSG5) for human VDR (pSG5-hVDR) and mouse PPAR 2 (pSG5-mPPAR 2) is driven by the SV40 early promoter fused with the rabbit -globin intron III (Green et al. 1988) . The validity of these expression plasmids was confirmed by the reporter assay using the reporter plasmids that have the canonical hormone-responsive elements (Sasaki et al. 1995 , Kawai et al. 2004 and data not shown). To prepare VDRdeletion constructs, the cDNA for human VDR (pSG5-hVDR) was amplified by PCR with the specific primers to generate PCR products including VDR-D1 (codon 20-427), D2 (codon 89-427) and D3 (codon 20-125). These DNA fragments were digested with EcoRI and BamHI and ligated into the mammalian expression plasmid, pSG5, to generate pSG5-hVDR-D1, D2 and D3. DNA sequencing was performed to confirm the identity of all the constructed plasmids. Dr Makoto Makishima (Nippon University, Japan) provided GST-FXR, in which the ligand-binding domain (LBD) of human FXR (codon 193-472) was fused to the open reading frame of GST cDNA in pGEX-4T-1 plasmid (Pharmacia). GST-VDR that had full-length VDR (1-427) was a gift from Dr Rajiv Kumar (Mayo Clinic and Foundation, USA) (Craig & Kumar 1996) .
Cell culture and transient transfection
CV1 cells and HepG2 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin G (100 units/ml) and streptomycin (100 µg/ml) at 37 C under 5%/95% air. By the calcium-phosphate technique (Sasaki et al. 1995) , the cells were cotransfected with 1·8 µg reporter gene, 3·6 µg -galactosidase expression vector (Sasaki et al. 1995) , and the expression plasmids for the receptors. HepG2 cells were transfected with 700 ng pCMX-BSEP-Luc, 70 ng expression plasmid (pCMX-rFXR) (Forman et al. 1995) , 1 µg -galactosidase expression vector and 300 ng empty vector per well by the lipofection method (Gibco-BRL). After transfection for 24 h (CV1) or 5 h (HepG2), the medium was replaced with fresh DMEM containing 10% dextran-charcoal-stripped FBS (10% DCC serum) in the presence or absence of 1 µM RA, T 3 , D3 or 5 µM troglitazone, or 22(R)-HC. After 24-h incubation, the cells were harvested, and the luciferase activity was measured. Transfection efficiencies were normalized by a -galactosidase assay.
GST pull-down assay E. coli (DH5 ) transformed with the GST-FXR or GST-VDR were induced with 0·1 mM isopropyl-1-thio--galactopyranoside (ITGP) for 4 h. The E. coli pellet was sonicated and the fusion proteins were mixed with glutathione-Sepharose beads (Amersham Pharmacia Biotech) for purification. Receptor proteins including RAR , TR 1, PPAR 2, LXR and VDR were in vitro translated with rabbit reticulocyte lysates (Promega) in the presence of 35 S-methionine. Radiolabeled receptors were incubated with GST fusion proteins (approximately 1 µg/sample) in the binding buffers for GST-FXR (140 mM KCl, 20 mM Tris HCl (pH 7·5), 0·05% Nonidet P-40 (NP-40), 0·5 mM phenilmethylsulfonyl fluoride (PMSF) and 1 mM dithiothreitol) or for GST-VDR (150 mM NaCl, 20 mM Tris HCl (pH 7·5), 0·3% NP-40, 1 mM DTT, 0·5 mM PMSF, 2 µg/ml leupeptin and 2 µg/ml aprotinin) for 3 h at 4 C, and washed with the binding buffer three times. Bound protein was analyzed by 10-14% SDS-PAGE and visualized by the BAS-1000 autoradiography system (Fuji Film, Tokyo, Japan) (Kawai et al. 2004) .
RNA isolation, cDNA synthesis and quantitative real-time detection PCR (RT-PCR)
RNA isolation from HepG2 cells and cDNA synthesis were performed as described previously (Kawai et al. 2004) . The cDNA for BSEP was amplified with the forward primer 5 -CCACTTCTGCCTTAGACACA-3 and the reverse primer 5 -CATGACAGCAATGATAT CCG-3 (134 bp PCR product). The cDNA for the human SHP gene was amplified with the forward primer 5 -ggaatatgcctgcctgaaag-3 and the reverse primer 5 -tcggaatggacttgagggt-3 (194 bp PCR product). The cDNA for the human I-BABP gene was amplified with the forward primer 5 -tcacttggtcccagcacta-3 and the reverse primer 5 -cttgtcacccacgatctct-3 (182 bp PCR product). The -actin cDNA was amplified with the forward primer (5 -GGGCATGGGTCAGAAGGATT-3 ) and the reverse primer (5 -GAGGCGTACAGGGA TAGCAC-3 ) to generate a 302 bp product. We designed the primer sets to encompass introns 27, 1 and 3 in the genome of the BSEP, SHP and I-BABP gene respectively. Real-time detection PCR was performed with LightCycler (Roche), and the optimal buffer conditions were determined for each template. The parameters for the PCR amplification of the BSEP, SHP and I-BABP genes were denaturation at 95 C for 10 s and annealing at 62 C for 10 s, followed by elongation at 72 C for 5 s.
Statistical analysis
Each experiment was performed in duplicate and repeated more than three different times; each result is expressed as the mean S.D. Statistical significance was determined with the analysis of variance (ANOVA) and Fisher's protected least significant difference (PLSD) test. P<0·05 was considered to be significant.
Results
The effect of nuclear receptors and their ligands on the transactivation by FXR/CDCA
We initially utilized the luciferase reporter gene in which the thymidine kinase (tk) promoter is fused to six copies of FXRE, originally identified as the ecdysone response element (EcRE) in the insect hsp27 gene (Fig. 1A ) (Forman et al. 1995) . This artificial reporter gene (EcRE) 6 -tk-Luc, and the FXR expression plasmid (pCMX-rFXR) (Forman et al. 1995) were cotransfected into CV1 cells together with the expression plasmids for RAR , TR 1, VDR, PPAR 2 or LXR . It should be noted that, without FXR or CDCA, (EcRE) 6 -tk-Luc was not transactivated by liganded or unliganded RAR , TR 1, VDR, PPAR 2 or LXR (data not shown). As reported, CDCA and FXR stimulated the luciferase activity (Fig. 1B) . In the presence of D3, VDR exhibited a potent suppressive effect on the luciferase activity of (EcRE) 6 -tk-Luc, whereas the effects of other ligands/ receptors were not statistically significant. Subsequently, we prepared reporter genes in which the luciferase gene was fused to the natural promoter of BSEP, SHP and I-BABP ( Fig. 2A) . In the presence of CDCA, FXR enhanced the transcriptional activities of these promoters in CV1 cells. Interestingly, ligand-dependent transcriptional repression by VDR was again detected in all three promoters (Fig. 2B-D) . Although bile acid is known to bind not only with FXR but also with VDR (Makishima et al. 2002) , VDR without D3 did not affect the basal transactivation by FXR/CDCA, presumably due to the low affinity of CDCA for VDR (Makishima et al. 2002) . TZD-bound PPAR 2 inhibited the I-BABP promoter (Fig. 2D) , whereas its inhibition of the promoter of BSEP or SHP was not significant (Fig. 2B and C) . Unliganded TR suppressed the I-BABP promoter stimulated by CDCA/FXR, and the inhibition was released by T 3 (Fig.  2D) . Although this suggested the presence of a cryptic T 3 -responsive element (TRE) in the I-BABP promoter, I-BABP-Luc was not stimulated by liganded-TR 1 in the absence of FXR/CDCA (data not shown). In other combinations, the difference of transcriptional activity in the presence or absence of ligands was not significant. It was reported that the SHP and I-BABP genes are regulated by LXR (Goodwin et al. 2003) and PPAR 2 (Landrier et al. 2005) respectively. As shown in Fig. 2C and D, however, liganded LXR and PPAR 2 did not affect the activities of these promoters driven by FXR/CDCA. Without FXR or CDCA, BSEP-, SHP-or IBABP-Luc was not affected by the RAR , TR 1, VDR, PPAR 2 or LXR in the presence or absence of cognate ligands (data not shown).
VDR-DBD is not required for the repression of the transactivation of BSEP promoter by CDCA/FXR
Since the expression of BSEP is known to be strictly regulated by FXR (Wagner et al. 2003) , we focused on the inhibition of the BSEP promoter by D3/VDR in the liver.
In the absence of VDR expression, D3 did not exhibit a repressive effect (data not shown), excluding the possibility that D3 may affect the function of FXR. The transactivation of the BSEP promoter by CDCA/FXR was suppressed in a D3-dependent manner (Fig. 3A) . The half-maximal inhibition was approximately 1-10 nM. To map the VDR region involved in this cross-talk, we generated three deletion mutants (Fig. 3B ): VDR-D1 lacking the A/B region, VDR-D2 lacking both the A/B region and DNA-binding domain (DBD), and VDR-D3 lacking the A/B region and the LBD. All the constructs were designed to harbor the hinge region (D-domain) that is required for nuclear localization (Luo et al. 1994) . Interestingly, D3-dependent transcriptional repression was observed not only in VDR-D1 but also in VDR-D2 that lacks DBD (Fig. 3C) . These results indicate that VDR-LBD is sufficient for the repression of the transactivation of BSEP promoter by CDCA/FXR. Because the hepatic expression of VDR is not so high, we wanted to determine whether endogenous VDR is able to mediate the D3-dependent inhibition. To this end, we cotransfected BSEP-Luc and the expression plasmid for FXR into human hepatoblastoma cells, HepG2, and observed that the CDCA-dependent transactivation is repressed by the administration of D3 (Fig. 3D ). This suggests that the suppressive effect by D3 is mediated via the endogenous VDR in HepG2 cells.
VDR specifically interacts with FXR in vitro
To explore the molecular mechanism of D3/VDRdependent inhibition, we generated GST-FXR and GST-VDR in which GST protein was fused to FXR-LBD or full-length VDR (Fig. 4A) , and performed GST pull-down assay (Fig. 4B-D) . In the presence of CDCA and specific ligands for receptors studied in Figs 1 and 2 , VDR, but not RAR , PPAR 2 or LXR , interacted with GST-FXR. A weak interaction between TR 1 and GST-FXR was also detected. As Fig. 4C shows, the interaction between VDR and FXR is independent of D3. We also performed a reciprocal experiment with 35 S-labeled FXR and the GST-VDR, in which GST was fused with full-length human VDR. Fig. 4D shows that the radiolabeled FXR interacted with the GST-VDR in a D3-independent fashion. 
Endogenous expression of the BSEP and SHP genes in HepG2 cells and the I-BABP gene in Caco-2 cells stimulated by CDCA is suppressed by D3
We investigated the effect of D3/VDR on BSEP mRNA, using real-time RT-PCR. As shown in Fig. 5A and B, the BSEP mRNA was stimulated by the administration of CDCA and was reduced to approximately 40% in the presence of D3. A similar result was obtained from RT-PCR for the SHP gene in HepG2 cells (Fig. 5C  (lanes 1-3) and D). Caco-2 cells are known to have the endogenous expression of the I-BABP, VDR and FXR genes. We studied the expression of the I-BABP gene in this cell line, and found that addition of 1 µM D3 inhibited the I-BABP gene activated by CDCA (Fig. 5C  (lanes 4-6) and E). These results suggest that D3 suppresses the CDCA/FXR-dependent expressions of the BSEP and SHP genes in HepG2 cells and that of the I-BABP gene in Caco2 cells.
Discussion
We have shown that D3-bound VDR inhibits the transactivation driven by CDCA/FXR. Since D3/VDR suppressed the CDCA/FXR-dependent transactivation of canonical FXRE fused to the heterologous tk promoter (Fig. 1B) , liganded VDR was believed to target directly the transactivation function of FXR. However, the molecular mechanism of the ligand-dependent inhibition of transcription by nuclear receptors, including D3/VDR, has been poorly understood. The squelching of RXR, p160 family and CBP/p300 does not account for this inhibition, because not only VDR but also TR 1, RAR , LXR and PPAR 2 associate with these nuclear factors. In agreement with this, D3/VDR-dependent repression was not affected by the overexpression of SRC1, CBP, p300 and the deletion mutant of p300 that has the N-terminal receptor-interacting domain but lacks the HAT domain (Ogryzko et al. 1996 ) (data not shown). Recently, FXR has been reported to associate with non-HAT coactivators, including TRAP220 (Pineda Torra et al. 2004 ) and PGC1 (Savkur et al. 2005a) , both of which also interact with VDR as well as TR 1 (McKenna & O'Malley 2002 , Zhang et al. 2004 , Savkur et al. 2005b . However, the overexpression of wild-type PGC1 or wildor dominant negative-type TRAP220 (Yuan et al. 1998 ) had no effect on D3/VDR-dependent inhibition (data not shown). On the other hand, VDR has been recently reported to associate with the Williams syndrome transcription factor (WSTF) that has ATP-dependent chromatin-remodeling activity (Kitagawa et al. 2003) . Moreover, Yanagisawa et al. (2002) reported that GCN5 and TRRAP/PAF400 enhance the ligand-dependent transactivation by multiple receptors including VDR. The association of these cofactors with FXR remains to be investigated. The D3/VDR-mediated negative regulation has been reported in several genes, including parathyroid hormone (PTH) (Demay et al. 1992) , granulocytemacrophage colony-stimulating factor (GM-CSF) (Towers et al. 1998 ) and 25-hydroxy-vitamin D 3 -1--hydroxylase (Murayama et al. 1999) . Towers et al. (1998) proposed the 'two-step model', in which D3-bound VDR competes to bind the composite DNA site that may be recognized by VDR as well as a transcription factor, NFAT1. In the current study, however, the inhibition of transactivation by CDCA/FXR did not require VDR-DBD, which is essential for DNA-binding (Fig. 3C) . Hence, competition between FXR and VDR for binding FXRE is unlikely. This may also exclude the possibility that, via the classical VDRE, D3-bound VDR may induce some factor that can suppress the transactivation by CDCA/FXR. Sakuma et al. (2003) reported that the transactivation by PPAR and its ligand, clofibric acid, is inhibited by D3-bound VDR, and not by estrogen/ estrogen receptor or dexamethasone/glucocorticoid receptor. Intriguingly, this inhibitory effect on PPAR requires only VDR-LBD, and not the DBD. D3-bound VDR may target a common cofactor for LBD of FXR and PPAR (Sakuma et al. 2003) . Our GST pull-down assay indicated that FXR-LBD interacts with VDR, but not RAR , PPAR 2 and LXR (Fig. 4B) . We also found that TR 1 weakly interacted with GST-FXR (Fig 4B) . Because T3-bound TR inhibited CDCA/FXR-induced BSEP promoter significantly (Fig. 2B ), or had a tendency to repress the activation of EcRE (Fig. 1B) and SHP (Fig. 2C) , direct interaction of FXR with VDR and TR 1 may have a role in the transcriptional inhibition.
D3 has a close relationship with bile acid with respect to its biosynthesis and signal-transduction property. Both bile acid and 7-dehydrocholesterol, a precursor of D3, are synthesized from cholesterol in liver and skin respectively. Vitamin D is hydroxylated by CYP27 in the liver to form 25-hydroxyvitamin D; CYP27 also hydroxylates bile acids and cholesterol. Here, we have demonstrated that D3-bound VDR interferes with the function of FXR in the BSEP, I-BABP and SHP promoter. Thus, D3 and VDR have a profound effect on the signal transduction mediated by bile acid/FXR. Since the reduction in the expression of BSEP and I-BABP may inhibit the enterohepatic circulation of bile acid, D3 may affect the intestinal absorption of D3 itself (Arnaud et al. 1975) as well as lipophilic molecules, including T 3 /T 4 (DiStefano et al. 1993) , RA (Thompson & Strautnieks 2001) , TZD (Kawai et al. 2000) , and 22(R)-HC. Our results also suggest that D3/VDR downregulates SHP expression (Fig. 2C ). This may release the suppression of CYP7A1 gene, resulting in the consumption of cholesterol from which D3 is synthesized. The association with BsmI polymorphism was reported in primary biliary cirrhosis (PBC) (Halmos et al. 2000 , Vogel et al. 2002 . This polymorphism correlates with the length of singlet (A) repeat in the 3 untranslated region of the VDR gene and affects the expression level of its mRNA (Whitfield et al. 2001) . Although it has been postulated that D3 may modulate the immune response in this disease, our observations raise the additional possibility that the production and metabolism of bile acids may be modified by the alteration of the expression level of VDR.
To avoid the complication through the possible autoregulatory mechanisms, we employed HepG2 and Caco-2 cells, but not individual animals. However, in future, intensive investigation should be performed with the VDR-null mouse (Sutton & MacDonald 2003) .
